Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness

Saharnaz Sarlak; Delphine Marotte; Jessy Sirera; Arthur Karaulic; Alessandra Pierantoni; Meng-Chen Tsai; Roxane Sylvestre; Clement Molina; Arthur Gouraud; Aurélien Bancaud; Béatrice Cambien; Paraskevi Kousteridou; Marie Vidal; Joël Hérault; Jérôme Doyen; Maeva Dufies; Florent Morfoisse; Barbara Garmy-Susini; Frédéric Luciano; Gilles Pagès

doi:10.1002/ctm2.70330

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (5) : e70330 DOI: 10.1002/ctm2.70330

LETTER TO THE JOURNAL

Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness

Author information +

History +

PDF

Cite this article

Download citation ▾

Saharnaz Sarlak, Delphine Marotte, Jessy Sirera, Arthur Karaulic, Alessandra Pierantoni, Meng-Chen Tsai, Roxane Sylvestre, Clement Molina, Arthur Gouraud, Aurélien Bancaud, Béatrice Cambien, Paraskevi Kousteridou, Marie Vidal, Joël Hérault, Jérôme Doyen, Maeva Dufies, Florent Morfoisse, Barbara Garmy-Susini, Frédéric Luciano, Gilles Pagès. Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness. Clinical and Translational Medicine, 2025, 15(5): e70330 DOI:10.1002/ctm2.70330

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. Published online April 5, 2021.

[2]	Ensenyat-Mendez M, Llinàs-Arias P, Orozco JIJ, et al. Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer. Front Oncol. 2021; 11: 681476.

[3]	Obidiro O, Battogtokh G, Akala EO. Triple negative breast cancer treatment options and limitations: future outlook. Pharmaceutics. 2023; 15(7): 1796.

[4]	Mohan R, Grosshans D. Proton therapy—present and future. Adv Drug Deliv Rev. 2017; 109: 26-44.

[5]	Mirjolet C, Nicol A, Limagne E, et al. Impact of proton therapy on antitumor immune response. Sci Rep. 2021; 11(1): 13444.

[6]	Lupu-Plesu M, Claren A, Martial S, et al. Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma. Oncogenesis. 2017; 6(7): e354.

[7]	Penco-Campillo M, Molina C, Piris P, et al. Targeting of the ELR+CXCL/CXCR1/2 pathway is a relevant strategy for the treatment of paediatric medulloblastomas. Cells. 2022; 11(23): 3933.

[8]	Nathanson SD, Detmar M, Padera TP, et al. Mechanisms of breast cancer metastasis. Clin Exp Metastasis. 2022; 39(1): 117-137.

[9]	Kong D, Zhou H, Neelakantan D, et al. VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk. Oncogene. 2021; 40(5): 964-979.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.